Compare SUPN & COCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | COCO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | 2012 | 2021 |
| Metric | SUPN | COCO |
|---|---|---|
| Price | $49.87 | $53.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $61.60 | $56.75 |
| AVG Volume (30 Days) | ★ 632.9K | 552.1K |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.16 |
| EPS | N/A | ★ 1.15 |
| Revenue | ★ $681,539,000.00 | $609,286,000.00 |
| Revenue This Year | $8.32 | $18.41 |
| Revenue Next Year | $23.64 | $13.70 |
| P/E Ratio | ★ N/A | $46.47 |
| Revenue Growth | 4.54 | ★ 23.12 |
| 52 Week Low | $29.16 | $25.79 |
| 52 Week High | $57.65 | $56.46 |
| Indicator | SUPN | COCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 53.81 |
| Support Level | $49.41 | $51.91 |
| Resistance Level | $52.34 | $56.46 |
| Average True Range (ATR) | 1.62 | 1.87 |
| MACD | -0.21 | -0.27 |
| Stochastic Oscillator | 38.94 | 50.69 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.